Cargando…
Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
SIMPLE SUMMARY: A relevant proportion of patients with neuroendocrine tumors (NET) develop carcinoid heart disease (CHD). This rare cardiac condition leads to worsened survival rates in patients with NET. In this study, we investigated various biomarkers in the blood that could detect and, more spec...
Autores principales: | Levy, Sonja, Kilgallen, Aoife B., Korse, Catharina M., Oerlemans, Marish I. F. J., Sluijter, Joost P. G., van Laake, Linda W., Valk, Gerlof D., Tesselaar, Margot E. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139809/ https://www.ncbi.nlm.nih.gov/pubmed/35625964 http://dx.doi.org/10.3390/cancers14102361 |
Ejemplares similares
-
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010) -
The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008) -
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)